Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Yttrium-90 × Clear all

NCT05620771 2025-10-20

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Phase 2 Suspended

Gastrointestinal

Carcinoma, Hepatocellular